What medications are recommended for an otherwise healthy adult with food‑borne illness or traveler’s diarrhea in India?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment for Food Poisoning/Traveler's Diarrhea in India (Adult)

For an otherwise healthy adult with traveler's diarrhea in India, azithromycin is the first-line antibiotic of choice due to high rates of fluoroquinolone-resistant Campylobacter in this region. 1

Treatment Algorithm Based on Severity

Mild Diarrhea (tolerable, doesn't interfere with activities)

  • No antibiotics needed 1
  • Use loperamide (4 mg first dose, then 2 mg after each loose stool, max 16 mg/24 hours) OR bismuth subsalicylate 1
  • Maintain hydration

Moderate Diarrhea (distressing or interferes with plans)

  • Azithromycin is preferred: 1000 mg single dose OR 500 mg daily for 3 days 1
  • Can add loperamide as adjunctive therapy (same dosing as above) 1
  • Fluoroquinolones (ciprofloxacin 750 mg or levofloxacin 500 mg) are alternatives but have significant resistance in India 1

Severe Diarrhea (incapacitating) or Dysentery (bloody stools with fever)

  • Azithromycin is mandatory - this is the only appropriate choice 1
    • Dosing: 1000 mg single dose OR 500 mg daily for 3 days
  • Do NOT use rifaximin - it doesn't cover invasive pathogens like Campylobacter, Shigella, or Salmonella 1
  • Do NOT use fluoroquinolones as first-line - only weak recommendation for severe non-dysenteric cases 1
  • Can add loperamide for symptom relief, but stop immediately if dysentery worsens 1

Critical India-Specific Considerations

India and Southeast Asia have extremely high rates (>90%) of fluoroquinolone-resistant Campylobacter, making azithromycin superior to levofloxacin for clinical cure in this region 1. The guidelines explicitly state to "use empirically as first line in Southeast Asia and India to cover fluoroquinolone resistant Campylobacter" 1.

Key Clinical Pitfalls to Avoid

  1. Don't continue loperamide if symptoms worsen or bloody diarrhea develops - this can worsen invasive infections 1

  2. Don't use rifaximin for febrile or bloody diarrhea - it's only effective for non-invasive pathogens and is contraindicated when Campylobacter, Salmonella, or Shigella are suspected 1

  3. Don't assume fluoroquinolones will work in India - resistance patterns make them unreliable as empiric therapy 1

  4. Recognize true dysentery - gross blood mixed throughout stool in the toilet bowl, not just streaks on toilet paper (which suggests hemorrhoids) 1

When to Seek Further Care

  • Symptoms persist beyond 24 hours despite antibiotic treatment
  • Development of high fever (≥38.5°C) with signs of sepsis 2
  • Diarrhea lasting >14 days (persistent diarrhea requiring microbiologic testing) 1
  • Severe dehydration despite oral rehydration

Evidence Strength

The recommendation for azithromycin in India carries a strong recommendation with moderate-to-high level of evidence from the 2017 Journal of Travel Medicine guidelines 1, which specifically address geographic resistance patterns. This supersedes older recommendations favoring fluoroquinolones, as the evidence demonstrates superior clinical cure rates with azithromycin in regions with high fluoroquinolone resistance 1.

Single-dose regimens are as effective as 3-day courses for both azithromycin and fluoroquinolones, supporting simplified treatment approaches 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.